49(top 2%)
papers
1.3K(top 2%)
citations
16(top 2%)
h-index
37(top 1%)
g-index
49
all documents
1.4K
doc citations
663
citing journals

Top Articles

#TitleJournalYearCitations
1Ebola and Marburg Viruses Replicate in Monocyte‐Derived Dendritic Cells without Inducing the Production of Cytokines and Full MaturationJournal of Infectious Diseases2003268
2A smartphone-read ultrasensitive and quantitative saliva test for COVID-19Science Advances2021175
3Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 studyBlood2018166
4Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma CellsPLoS ONE2012128
5Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancerOncotarget201586
6A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib eraBlood201881
7Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and reviewEuropean Journal of Haematology201973
8Desmopressin (DDAVP) in the management of patients with congenital bleeding disordersHaemophilia201466
9Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cellsMolecular Carcinogenesis201445
10Bortezomib in Plasmablastic Lymphoma: A Case Report and Review of the LiteratureOnkologie201341
11MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic LeukemiaCancer Research201741
12COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasmaBone Marrow Transplantation202027
13Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic ReviewJournal of the National Cancer Institute202125
14Packed Red Blood Cell Transfusion Causes Greater Hemoglobin Rise at a Lower Starting Hemoglobin in Patients with Subarachnoid HemorrhageNeurocritical Care200824
15The utility of hyperbaric oxygen therapy in post-transplant cyclophosphamide-induced hemorrhagic cystitis: a case report and review of the literatureJournal of Medical Case Reports202123
16Gαo potentiates estrogen receptor α activity via the ERK signaling pathwayJournal of Endocrinology201220
17Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphomaBlood Advances202217
18Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patientsTransfusion Medicine202115
19A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)Blood201612
20A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu–Negative Metastatic Breast CancerClinical Breast Cancer200811
21A Validation Study of the Mini-IPIP Five-Factor Personality Scale in Adults With CancerJournal of Personality Assessment202011
22Evaluation of Extracellular Matrix Composition to Improve Breast Cancer ModelingTissue Engineering - Part A202111
23Disruption of pre-B-cell receptor signaling jams the WNT/β-catenin pathway and induces cell death in B-cell acute lymphoblastic leukemia cell linesLeukemia Research20159
24Primary Dural Diffuse Large B-cell Lymphoma: A Comprehensive Review of Survival and Treatment OutcomesClinical Lymphoma, Myeloma and Leukemia20208
25Quantifying Breast Cancer-Driven Fiber Alignment and Collagen Deposition in Primary Human Breast TissueFrontiers in Bioengineering and Biotechnology20217
26High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignanciesLeukemia Research20216
27Glyceollins Trigger Anti-Proliferative Effects in Hormone-Dependent Aromatase-Inhibitor-Resistant Breast Cancer Cells through the Induction of ApoptosisInternational Journal of Molecular Sciences20226
28RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literatureCancer Genetics20195
29Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL StudyTargeted Oncology20215
30Apremilast in Recalcitrant Cutaneous DermatomyositisJAMA Dermatology20225
31Quantitative assessment of chromosome instability induced through chemical disruption of mitotic progressionCell Cycle20164
32Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancyLeukemia Research20214
33Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimenLeukemia Research20214
34Outcomes of mentored, grant‐funded fellowship training in haemostasis /thrombosis: findings from a nested case–control survey studyHaemophilia20123
35A Systemic Review of CD5-Negative Mantle Cell Lymphoma Identifies Potential Clinical and Biological ImplicationsBlood20163
36Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy20223
37Cancer of the Indiana Pouch: A Case Report and Review of the LiteratureClinical Genitourinary Cancer20132
38CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantageLeukemia and Lymphoma20222
39Reduction in Cell Viability and in Homeobox Protein Levels Followingin VitroExposure to δ-tocopherol in Acute Myeloid LeukemiaNutrition and Cancer20161
40Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Maintenance TrialBlood20201
41COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 PatientsBlood20201
42COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High MortalityBlood20201
43Abstract 2737: Quantitative assessment of chromosome instability induced through chemical disruption of mitotic progressionBlood20160
44Targeting MALT1 with the Small Molecule Inhibitor MI2 Induces a Caspase-Dependent Apoptosis and Inhibits the NF-κb Pathway in Chronic Lymphocytic Leukemia Primary CellsBlood20160
45Long-Term Outcomes of Autologous Hematopoietic Cell Transplantation Using Melphalan and Total Body Irradiation Conditioning in Multiple MyelomaBlood20160
46The Paracaspase MALT1 Acts Independently of Pre-B-Cell Receptor Signaling As a Key Factor in Leukemic Cell Survival in Precursor B-Cell Acute Lymphoblastic LeukemiaBlood20190
47Central Nervous System Prophylaxis Is Required and Associated with a Prolonged Overall Survival in Both Early and Advanced-Stage Primary Adrenal/Renal Diffuse Large B-Cell LymphomaBlood20190
48Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)Blood20200
49Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1Nutrients20230